Sunflower Therapeutics
CAMBRIDGE, Massachusetts · Biotechnology
Sunflower Therapeutics is a unique biotech with a mission to transform bioeconomies worldwide by creating accessible solutions for protein product development and commercial manufacturing. Using our core technologies – an efficient host, data-driven methods for process development, and continuous biomanufacturing equipment – our team aims to democratize bioprocessing.
Key facts
- Headquarters
- CAMBRIDGE, Massachusetts
- Employees
- 21
- Industries
- Biotechnology
- Status
- Private
- Website
- sunflowertx.com
- Company page
Recent activity at Sunflower Therapeutics
- : Sunflower Therapeutics Collaborates with SK bioscience on Cost-Effective HPV Vaccine and Receives First Milestone Payment.
- : Sunflower Therapeutics secures a $2.36 million NIH SBIR grant to develop a continuous cell disruption platform for VLP-based vaccine manufacturing, aiming to enhance production efficiency.
- : Sunflower Therapeutics has launched the Daisy Petal™ Perfusion Bioreactor System through a distribution agreement with PharmNXT Biotech.
- : Sunflower Therapeutics Closes $3M Agreement for Future Equity (SAFE) with Oversubscription
- : SK bioscience Invests $2M in Sunflower Therapeutics for Research and Development Collaborations
- : Sunflower Therapeutics PBC
- : Sunflower Therapeutics PBC
Sunflower Therapeutics funding history
| Date | Round | Amount |
|---|---|---|
| Sep 2025 | Grant | $2.4M |
| May 2024 | Seed | $2.0M |
| Oct 2022 | Seed | $610K |
Leadership
- Kathryn Golden, Director
- J. Christopher Love, Director
- Kerry Love, Executive Officer, Director
- Tom Heer, Chief Financial Officer
Verified email and direct lines for Sunflower Therapeutics’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
Sunflower Therapeutics files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Sunflower Therapeutics in the news
- Empowering Europe's protein bioeconomy with smarter, faster, and more adaptable continuous production methods - Innovation News Network (Oct 10, 2025)
- Sunflower Therapeutics Receives NIH SBIR Funding to Develop an Automated, Continuous Cell Disruption Platform for VLP-Based Vaccine Manufacturing - Business Wire (Sep 03, 2025)
Companies similar to Sunflower Therapeutics
- CytoDyn · Biotechnology
- Nami Surgical · Biotechnology
- Moonwalk Biosciences · Biotechnology
- PDS Biotech · Biotechnology
- Quantitative Biosciences Institute · Biotechnology
About Sunflower Therapeutics: questions and answers
What does Sunflower Therapeutics do?
Sunflower Therapeutics is a unique biotech with a mission to transform bioeconomies worldwide by creating accessible solutions for protein product development and commercial manufacturing. Using our core technologies – an efficient host, data-driven methods for process development, and continuous biomanufacturing equipment – our team aims to democratize bioprocessing.
Where is Sunflower Therapeutics headquartered?
Sunflower Therapeutics is headquartered in CAMBRIDGE, Massachusetts.
How many employees does Sunflower Therapeutics have?
Sunflower Therapeutics has about 21 employees.
Has Sunflower Therapeutics raised funding?
Yes. Fundz has recorded 3 funding events for Sunflower Therapeutics. The most recent, Grant of $2.4M, was in Sep 2025.
What is the latest news on Sunflower Therapeutics?
On Sep 18, 2025, Sunflower Therapeutics Collaborates with SK bioscience on Cost-Effective HPV Vaccine and Receives First Milestone Payment.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy